Showing results (31-40 of 106) with videos related to
Sort By:
Pageof 11
Immunological Reviews|October 25, 2011
Science gone translational: the OX40 agonist storyAndrew D Weinberg, Nicholas P Morris, Magdalena Kovacsovics-Bankowski, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Analysis of MHC class II presentation of particulate antigens of B lymphocytesL Vidard, M Kovacsovics-Bankowski, S K Kraeft, et al.Dermatology (Basel, Switzerland)|November 16, 2005
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemiaE Gambillara, E Laffitte, N Widmer, et al.Experimental Hematology & Oncology|October 7, 2016
Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with <i>JAK2</i><sup>V617F</sup> allelic burdenMagdalena Kovacsovics-Bankowski, Todd W Kelley, Olga Efimova, et al.British Journal of Cancer|May 11, 2006
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphomaF Buchegger, C Antonescu, A Bischof Delaloye, et al.Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 8, 2004
Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case reportNermin Halkic, Riadh Ksontini, Beatrix Scholl, et al.The Journal of Biological Chemistry|May 12, 1995
Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregationT J Kovacsovics, C Bachelot, A Toker, et al.The Journal of Biological Chemistry|December 20, 1996
D3 phosphoinositides and outside-in integrin signaling by glycoprotein IIb-IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetateJ H Hartwig, S Kung, T Kovacsovics, et al.Schweizerische Medizinische Wochenschrift|May 17, 2000
[Autologous transplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I: patients]P Medinger, J D Tissot, G Nicoloso de Faveri, et al.Cytotherapy|November 6, 2008
Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cellsM Kovacsovics-Bankowski, K Mauch, A Raber, et al.Pageof 11